An Ultra-Long Acting Buprenorphine Prodrug (AM-510) for Opioid Use Disorder
CROI 2026 Feb 22-25 Denver
Ashrafi Sultana1, Brian P. Kearney2, Sunday Ogundepo1, Mohammad Ullah Nayan1, Nam Thai Hoang Le1, Brandon W. Hanson1, Brady Sillman1, Howard E. Gendelman1, Alborz Yazdi2, and Benson Edagwa1. 1University of Nebraska Medical Center, Omaha, NE, USA
2Exavir Therapeutics, Inc., San Francisco, CA, USA.
